Riskpilot← Back to searchSign inGet full accessTRANGSRUD MEDICAL AS
ASActiveOrg 924430303Vangsvegen 163C, 2321 HamarGeneral medical practice activities · NACE 8621Est. 20202 employees
Revenue 2024
NOK 3,8M
-3% vs 2023
EBITDA margin
5.6%
-46% vs 2023
Equity ratio
7.8%
Financial strength
Net profit 2024
NOK 60K
-12% vs 2023
| Revenue | NOK 3,8M | -3% |
| EBITDA | NOK 212K | -46% |
| Net profit | NOK 60K | -12% |
| Total assets | NOK 801K | -42% |
| Equity | NOK 63K | -76% |
| Employees | 2 | — |
Legal name
TRANGSRUD MEDICAL AS
Org number
924430303
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
17. januar 2020
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Allmennmedisinsk behandling, kurs-, foredrags- og undervisningsvirksomhet, utarbeidelse av spesialisterklæringer og sakkyndige oppdrag, konsulentvirksomhet og forvaltning av selskapets kapital og ressurser i form av investeringsvirksomhet, deltakelse i andre selskaper, finansforvaltning, kjøp, drift, oppføring og rehabilitering av fast eiendom.
Address
Vangsvegen 163C, 2321 Hamar
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 468 | 2 975 | 2 866 | 3 931 | 3 815 |
| Staff expenses | −89 | −14 | −434 | −1 574 | −1 979 |
| EBITDA | 1 090 | 1 561 | 440 | 393 | 212 |
| Depreciation & amort. | −216 | −251 | −251 | −238 | −232 |
| EBIT | 874 | 1 311 | 189 | 155 | −20 |
| Net financials | −8 | −5 | −0 | −39 | 100 |
| Profit before tax | 866 | 1 306 | 189 | 117 | 80 |
| Tax | 191 | 293 | 63 | 49 | 19 |
| Net profit | 676 | 1 013 | 126 | 68 | 60 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 904 | 2 892 | 1 248 | 1 391 | 801 |
| Equity | 706 | 68 | 195 | 263 | 63 |
| Long-term debt | 967 | 820 | 770 | 614 | 216 |
| Short-term debt | 232 | 2 003 | 283 | 514 | 522 |
| Total debt | 1 198 | 2 823 | 1 053 | 1 128 | 738 |
EBITDA margin
5.6%
This company
15.8%
Market median
-65% vs market
20202024
Equity ratio
7.8%
This company
38.2%
Market median
-80% vs market
20202024
Return on equity
96.1%
This company
18.4%
Market median
+422% vs market
20202024
Net profit margin
1.6%
This company
8.1%
Market median
-80% vs market
20202024
Asset turnover
4.76×
This company
1.12×
Market median
+325% vs market
20202024
Debt / equity
11.79×
This company
0.62×
Market median
-1802% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Marshall Holding As
TRANGSRUD MEDICAL AS Board members of TRANGSRUD MEDICAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inge Marshall Trangsrud | Chairman | 0 companies |
| Hugo Andre Mowinckel Nilsen | Board of Directors | 0 companies |
| Øystein Dunker | Board of Directors | 0 companies |